🚀 Apply for £10k+ grants with our Startup Launch Kit
shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Notice of Intent to Publish a Funding Opportunity Announcement for NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)

    NOT-CA-24-070

    Opening date 19 Jul 2024, 12:00AM

    Closing date N/A

    Funding Opportunity Number: NOT-CA-24-070

    Opportunity Category: Discretionary

    CFDA Number(s): 93.398 -- Cancer Research Manpower

    Cost Sharing or Matching Requirement: No

    Posted Date: Jul 19, 2024 12:00:00 AM EDT

    Closing Date: N/A

    Eligible Applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,For profit organizations other than small businesses,Native American tribal governments (Federally recognized),County governments,Native American tribal organizations (other than Federally recognized tribal governments),Small businesses,Public and State controlled institutions of higher education,Private institutions of higher education,Others (see text field entitled "Additional Information on Eligibility" for clarification),Independent school districts,State governments,Public housing authorities/Indian housing authorities

    Description: The National Cancer Institute (NCI) intends to issue a notice of funding opportunity (NOFO) for the Research Specialist Award (R50) specifically for clinician scientists supporting NCI-funded clinical trials research. The Research Specialists Award is designed to encourage the development of stable research career opportunities for exceptional clinician scientists who want to continue to participate in the NCI clinical trials networks through leadership in the 1) development of clinical trials, 2) implementation of NCI clinical trials in their institutions, and 3) national service to the NCI clinical trials networks through participation in the scientific review committees, monitoring committees and other activities, but not serve as principal investigator of research project grants.� This Notice of Intent to Publish is being provided to allow sufficient time for applicants to develop strong applications.� Applications are limited to four per institution per receipt date including new (A0) and resubmissions (A1). NCI-designated cancer center consortia are considered one institution. NCI seeks a broad representation of institutions for this award mechanism and may take this into account when making funding decisions.� The NOFO is expected to be published in late summer 2024 with only one expected application due date of November 5, 2024. �

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept